Transforming growth factor β stabilizes p15(INK4B) protein, increases p15(INK4B)-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

Molecular and Cellular Biology

Volumn 17, Issue 5, 1997, Pages 2458-2467

  Sandhu, C ^a   Garbe, J ^b   Bhattacharya, N ^a   Daksis, J ^a   Pan, C H ^b   Yaswen, P ^b   Koh, J ^c   Slingerland, J M ^a   Stampfer, M R ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CELL; CELL CYCLE; CELL GROWTH; CELL TYPE; ENZYME ACTIVATION; ENZYME BINDING; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STABILITY;

EID: 0030974040     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.5.2458     Document Type: Article

References (77)

1. Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickson, and G. Peters. 1994. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9:1633-1640.
2. Brenner, A. J., and C. M. Aldaz. 1995. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res. 55:2892-2895.
3. ink4. Mol. Cell. Biol. 15:2682-2688.
4. Chirgwin, J. M. A. E. Przybyla, R. J. Macdonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299.
5. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545-5549.
6. Dulic, V., W. K. Kaufman, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
7. 1-S phase protein kinase. Science 257:1958-1961.
8. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, Jr., J. D. Iglehart and J. R. Marks. 1994. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301-1307.
9. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor supression. Cell 75:817-825.
10. Enders, G. H., J. Koh, A. K. Rustigi, C. Missero, and E. Harlow. 1995. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene 12:1239-1245.
11. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
12. Kip1. Oncogene. 13:2447-2457.
13. Flores-Rosas, H., Z. Kelman, F. B. Dean, Z. Pan, J. W. Harper, S. J. Elledge, M. O'Donnell, and J. Hurwitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme. Proc. Natl. Acad. Sci. USA 91:8655-8659.
14. Fynan, T. M., and M. Reiss. 1993. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit. Rev. Oncog. 4:493-540.
15. Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315-10319.
16. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function Genes Dev. 8:2939-2952.
17. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1022.
18. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588.
19. Hammond, S. L., R. G. Ham, and M. R. Stampfer. 1984. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA 81:5435-5439.
20. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261.
21. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
22. Harper, J. W., S. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
23. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the senomic instability of cancer cells. Cell 71:543-546.
24. Hengst, L., V. Dulic, J. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle regulated inhibitor of cyclin dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291-5294.
25. Kip1 accumulation durina the cell cycle. Science 271:1861-1864.
26. Hirai, H., M. F. Roussel, J.-Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18. are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
27. Hosobuchi, M., and M. Stampfer. 1989. Effects of the transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol. 25:705-713.
28. Iavarone, A., and J. Massagué. Personal communication.
29. Kamb, A., N. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. Day III, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
30. Kerbel, R. S. 1992. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer: malignant melanoma as a paradigm. Am. J. Pathol. 141:519-524.
31. Ko, T. C., H. M. Sheng, D. Reisman, E. A. Thompson, and R. D. Beauchamp; 1995. Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10:177-184.
32. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536-539.
33. LaBaer, J., M. Garrett, L. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. New functional activities for the p21 family of CDK inhibitors. Genes Dev., in press.
34. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
35. KIP2, a cyclin-dependent kinase inhibitor with a unique domain structure and tissue distribution. Genes Dev. 9:639-649.
36. Li, R., S. Waga, G. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537.
37. Li, Y., C. W. Jenkins, M. A. Nichols, and X. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent inhibitor p21. Oncogene 9:2261-2268.
38. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
39. Lukas, J., D. Parry, L. Aagaard, D. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503-506.
40. Massague, J., S. Cheifetz, M. Laiho, D. A. Ralph, F. M. B. Weis, and A. Zentella. 1992. Transforming growth factor-β. Cancer Surv. 12:81-103.
41. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
42. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
43. Morgan, D. O. 1995. Principles of Cdk regulation. Nature 374:131-134.
44. Murray, A. W. 1992. Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599-604.
45. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
46. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
47. Norbury, C. and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.
48. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1448-1451.
49. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res. 55:1436-1440.
50. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
51. CIP1 in muscle and other terminally differentiating cells. Science 267: 1024-1028.
52. INK4/MTS1 tumour suppressor gene product. EMBO J. 14:503-511.
53. Peters, G. 1994. Stifled by inhibitors. Nature 371:204-205.
54. Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene 12:1387-1396.
55. Pierce, D. F. J., M. D. Johnson, Y. Matzui, S. D. Robinson, L. I. Gold, A. F. Purchio, C. W. Daniel, B. L. M. Hogan, and H. Moses. 1993. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev. 7:2308-2317.
56. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
57. KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cells 78:59-66.
58. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
59. Poon, R., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet light. Mol. Biol. Cell 6:1197-1213.
60. Reed, S. I., E. Bailly, V. Dulic, L. Hengst, D. Resnitzky, and J. Slingerland. 1994. G1 control in mammalian cells. J. Cell Sci. Suppl. 18:69-73.
61. Revnisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
62. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/Cdk4. Nature 366: 704-707.
63. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-553.
64. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
65. Silbertein, G. B., and C. W. Daniel. 1987. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science 237:291-293.
66. Skapek, S. X., J. Rhee, D. B. Spicer, and D. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
67. Slingerland, J. M., L. Hengst, C.-H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683-3694.
68. Solomon, M. J. 1993. Activation of the various cyclin/cdc2 protein kinases. Curr. Opin. Cell Biol. 5:180-186.
69. Stampfer, M. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9:107-115.
70. Stampfer, M. R., and J. C. Bartley. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA 82:2392-2398.
71. Stampfer, M. R., C.-H. Pan, J. Hosoda, J. Bartholomew, J. Mendelsohn, and P. Yaswen. 1993. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous re-entry into the cell cycle. Exp. Cell Res. 208:175-188.
72. Stampfer, M. R., and J. M. Slingerland. Unpublished results.
73. Stampfer, M. R., P. Yaswen, M. Alhadeff, and J. Hosoda. 1993. TGF-β induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J. Cell. Physiol. 155:210-221.
74. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
75. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
76. Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
77. Zhang, H., G. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.